FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to obstetrics, and can be used to reduce blood loss in operative delivery in obstetric patients of high risk groups. For this purpose, intraoperatively immediately after the umbilical cord is crossed before the placenta is separated, Terlipressin preparation 0.4 mg is added with addition of 0.9 % sodium chloride solution and bringing the administered volume to 10 ml into the muscular tissue of the uterus through a uterine incision in equal doses of 0.2 mg into uterus incision angles.;EFFECT: method enables reducing blood loss in the obstetric patients of the high obstetric risk group in a combination with normalizing such cardiovascular parameters as cardiac output, systemic vascular resistance, cardiac index, arterial pressure in the absence of complications specific for the intravenous introduction.;1 cl, 1 tbl, 2 ex
展开▼
机译：领域：药物。发明：本发明涉及药物，即产科，可用于减少高危人群产科患者手术分娩中的失血。为此目的，在术中在脐带穿过后立即分离胎盘之前，在术中立即添加0.4 mg特利加压素制剂，并添加0.9％氯化钠溶液，并将给药量通过子宫注入子宫的肌肉组织中至10 ml以相等的剂量将0.2 mg的子宫切口切开至子宫切角。效果：该方法可通过将心输出量，全身血管阻力，心脏指数，动脉等心血管参数正常化来减少高产科高危人群产科患者的失血量没有静脉输注所特有的并发症时的最大压力; 1 cl，1 tbl，2 ex
展开▼
